OWCP - OWC Pharmaceutical Research Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.02M
Enterprise Value 33.72M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.19

Trading Information

Stock Price History

Beta (3Y Monthly) -5.71
52-Week Change 3-95.39%
S&P500 52-Week Change 34.18%
52 Week High 30.2145
52 Week Low 30.0066
50-Day Moving Average 30.0093
200-Day Moving Average 30.0198

Share Statistics

Avg Vol (3 month) 31.38M
Avg Vol (10 day) 3649.43k
Shares Outstanding 5228.78M
Float 226.79M
% Held by Insiders 11.21%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/1
Last Split Date 3Oct 26, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.93%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.12M
Net Income Avi to Common (ttm)-3.1M
Diluted EPS (ttm)-0.0490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.84M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)53k
Total Debt/Equity (mrq)9.06
Current Ratio (mrq)4.36
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-2.8M
Levered Free Cash Flow (ttm)-958.38k